Magnetar Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,270
Closed -$555K 1173
2025
Q1
$555K Buy
+6,270
New +$544K 0.01% 439
2022
Q3
Sell
-2,187
Closed -$91K 1530
2022
Q2
$91K Buy
2,187
+328
+18% +$22.3K ﹤0.01% 1331
2022
Q1
$188K Buy
1,859
+136
+8% +$15.1K ﹤0.01% 1065
2021
Q4
$254K Buy
1,723
+738
+75% +$165K ﹤0.01% 1101
2021
Q3
$247K Sell
985
-5,826
-86% -$2M ﹤0.01% 1044
2021
Q2
$3.15M Buy
6,811
+826
+14% +$355K 0.03% 511
2021
Q1
$2.94M Buy
+5,985
New +$3.11M 0.03% 490

Other funds holding WGS

Magnetar Financial's WGS Position: Q2 2025 in Review

Magnetar Financial sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 6,270 shares — an estimated $555K sold.

Magnetar Financial first reported a position in WGS in Q1 2021 and held it in 7 quarters. The position peaked at $3.15M in Q2 2021. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Magnetar Financial reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Magnetar Financial sold 6,270 GeneDx Holdings shares in Q2 2025, an estimated $555K.
  • Magnetar Financial first reported a position in GeneDx Holdings in Q1 2021 and held it in 7 quarters.
  • Magnetar Financial's GeneDx Holdings position peaked at $3.15M in Q2 2021.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Magnetar Financial's 13F filing for Q2 2025, filed 12 Aug 2025.